We are live on ! Find out more
DVAX

Dynavax Technologies

Delisted

DVAX was delisted on the 9th of February, 2026.

117 hedge funds and large institutions have $242M invested in Dynavax Technologies in 2019 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 50 increasing their positions, 25 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

367% more call options, than puts

Call options by funds: $5.79M | Put options by funds: $1.24M

100% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 25

22.9% more ownership

Funds ownership: 80.93%103.83% (+23%)

15% more capital invested

Capital invested by funds: $210M → $242M (+$31.9M)

8% less funds holding

Funds holding: 127117 (-10)

43% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 21

Holders
117
Holders Change
-10
Holders Change %
-7.87%
% of All Funds
2.57%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
12
Increased
50
Reduced
25
Closed
21
Calls
$5.79M
Puts
$1.24M
Net Calls
+$4.55M
Net Calls Change
+$2.9M
Name Holding Trade Value Shares
Change
Change in
Stake
SCM
26
Sio Capital Management
New York
$1.66M +$1.8M +465,299 New
Fidelity Investments
27
Fidelity Investments
Massachusetts
$1.62M -$622K -160,500 -26%
Susquehanna International Group
28
Susquehanna International Group
Pennsylvania
$1.17M +$846K +218,347 +199%
N
29
Nuveen
North Carolina
$1.07M +$221K +56,971 +23%
Bank of New York Mellon
30
Bank of New York Mellon
New York
$1.05M +$109K +28,022 +11%
RA
31
Royce & Associates
New York
$1.04M +$608K +156,800 +117%
DekaBank Deutsche Girozentrale
32
DekaBank Deutsche Girozentrale
Germany
$963K -$1.01M -260,000 -49%
MS
33
Maven Securities
Jersey
$931K +$1.03M +264,989 New
Deutsche Bank
34
Deutsche Bank
Germany
$755K -$819K -211,203 -50%
T. Rowe Price Associates
35
T. Rowe Price Associates
Maryland
$645K +$533K +137,567 +321%
Goldman Sachs
36
Goldman Sachs
New York
$633K -$364K -93,939 -35%
Swiss National Bank
37
Swiss National Bank
Switzerland
$561K +$147K +37,800 +32%
Citigroup
38
Citigroup
New York
$502K +$32.4K +8,370 +6%
California State Teachers Retirement System (CalSTRS)
39
California State Teachers Retirement System (CalSTRS)
California
$464K +$117K +30,092 +30%
AllianceBernstein
40
AllianceBernstein
Tennessee
$447K
Bank of America
41
Bank of America
North Carolina
$412K -$351K -90,538 -44%
ARTA
42
A.R.T. Advisors
New York
$382K +$346K +89,200 +509%
HP
43
Hikari Power
Japan
$377K
RhumbLine Advisers
44
RhumbLine Advisers
Massachusetts
$342K +$37.5K +9,670 +11%
Morgan Stanley
45
Morgan Stanley
New York
$326K -$1.48M -382,667 -81%
State of Wisconsin Investment Board
46
State of Wisconsin Investment Board
Wisconsin
$318K
Wells Fargo
47
Wells Fargo
California
$284K +$13.3K +3,436 +5%
Royal Bank of Canada
48
Royal Bank of Canada
Ontario, Canada
$278K +$261K +67,275 +641%
BBA
49
Baker Bros. Advisors
New York
$268K
New York State Common Retirement Fund
50
New York State Common Retirement Fund
New York
$247K +$69K +17,800 +35%

DVAX Hedge Fund Activity: Q3 2019 in Review

117 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Dynavax Technologies (DVAX) for Q3 2019, worth a combined $242M — up 15% from $210M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of DVAX and 12 opened new positions — a net loss of 9 holders — while 25 trimmed existing stakes and 50 added.

The largest buyer was Bain Capital Life Sciences Investors, opening a new position worth an estimated $32.8M. The largest seller was Franklin Resources, cutting an estimated $8.12M.

  • 117 institutional investors held Dynavax Technologies (DVAX) as of Q3 2019, down from 127 in Q2 2019.
  • Funds reported $242M of Dynavax Technologies stock for Q3 2019, up 15% quarter-over-quarter.
  • 12 funds opened new Dynavax Technologies positions in Q3 2019 and 21 closed out, a net change of -9 holders.
  • The largest Dynavax Technologies buyer in Q3 2019 was Bain Capital Life Sciences Investors, an estimated $32.8M added.
  • The largest Dynavax Technologies seller in Q3 2019 was Franklin Resources, an estimated $8.12M sold.

Based on aggregated 13F filings for Q3 2019.